Ketaneserinol as an agent to reduce intraocular pressure

Details Ketaneserinol as an agent to reduce intraocular pressure Ketaneserinol as an agent to reduce intraocular pressure

1993-01-05

1994-03-01

Fay, Zohreh A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514913, A61K 31505

Patent

active

052907813

ABSTRACT:
This invention relates to the use of ketanserinol as an ophthalmic therapeutic agent to reduce intraocular pressure and its method of use for treating glaucoma by systemic administration of ketanserinol, it salts, esters or prodrugs to a patient or more particularly, topically administering ketanserinol and salts thereof to the eye of a patient.

REFERENCES:
Biosis Abstract of Eur J Clin Pharmacol 32(3). 1987. 259-266. Persson et al.

Affiliated with

Also associated with

Rating

Ketaneserinol as an agent to reduce intraocular pressure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ketaneserinol as an agent to reduce intraocular pressure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketaneserinol as an agent to reduce intraocular pressure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-577274